VDAC2 and glioblastoma: Consistent with this hypothesis, deletion of VDAC2 in glioblastoma cells engineered to be BAX-dependent (i.e., ∆BAK) significantly inhibited apoptosis in response to BH3-mimetics (Fig. 5a and Supplementary Fig. 9a).